Published on
July 23, 2020
- 12:15 GMT
Novaliq Provides Development Update on CyclASol Topical Ophthalmic Solution for the Treatment of Dry Eye Disease
HEIDELBERG, GERMANY, July 23, 2020 /EINPresswire.com/ -- Novaliq GmbH, a pharmaceutical company focusing on first- and best-in-class ocular therapeutics, today provided a development update on its investigational water-free and preservative-free drug …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...